The use of areal bone mineral density (aBMD) in paediatric populations
has aroused some concern, as it fails to take the age-related increas
e in bone thickness into account. We have developed a measure of true
bone density, volumetric bone mineral density (vBMD), which is indepen
dent of age and height. In order to examine the relationship between g
rowth parameters, aBMD and vBMD, we studied patients with phenylketonu
ria (PKU, n = 40), chronic renal failure (CRF, n = 27) and chronic ast
hma (n = 19). aBMD of the femoral neck and the mid-femoral shaft was m
easured using dual energy X-ray absorptiometry (DXA), vBMD was calcula
ted on the basis of values of bone mineral content and bone dimension
provided by DXA, with the assumption that both sites are cylinders. aB
MD and vBMD were then compared with the normal reference, expressed as
a standard deviation score (SDS). aBMD and vBMD were normal in the fe
moral neck region of the PKU group, but aBMD, either standardized for
age or for height, was low in the femoral shaft region (p < 0.01). In
the CRF group, profound growth retardation was seen (mean height SDS,
-3.2) and aBMD and vBMD were both low in the femoral shaft region but
not in the femoral neck. In the asthma group, aBMD for age was low at
both sites, but vBMD did not differ from that seen in normal individua
ls. We conclude that the true vBMD provides a different interpretation
of bone density compared with aBMD and requires further evaluation in
paediatrics because of its age and height independence.